The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer.
 
Anna Jeter
Employment - AOA Dx
Leadership - AOA Dx
Stock and Other Ownership Interests - AOA Dx
 
Alba Galan
No Relationships to Disclose
 
Arturo Papaluca
No Relationships to Disclose
 
Ali Nejatie
No Relationships to Disclose
 
Emad Matanes
No Relationships to Disclose
 
Fouad Brahimi
No Relationships to Disclose
 
Amber Yasmeen
No Relationships to Disclose
 
Euridice Carmona
No Relationships to Disclose
 
Kathleen Oros Klein
No Relationships to Disclose
 
Sonja Billes
Consulting or Advisory Role - AOA Dx; Embr Labs; Escient Pharmaceuticals; Nutraceutical Corporation
 
Ahmed E. Dawod
Consulting or Advisory Role - AOA Dx
 
Prasad Gawande
Employment - AOA Dx
Stock and Other Ownership Interests - AOA Dx
 
Anne-Marie Mes-Masson
No Relationships to Disclose
 
Celia Greenwood
No Relationships to Disclose
 
Walter H. Gotlieb
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca; GlaxoSmithKline; Merck
Travel, Accommodations, Expenses - Intuitive Surgical
 
H. Uri Saragovi
Leadership - Mimetogen Pharmaceuticals; Otonomy
Stock and Other Ownership Interests - Mimetogen Pharmaceuticals; Otonomy
Honoraria - Mimetogen Pharmaceuticals; Otonomy
Consulting or Advisory Role - AOA Dx
Patents, Royalties, Other Intellectual Property - AOA Dx; Mimetogen Pharmaceuticals; Otonomy